DexCom Statistics

Share Statistics

DexCom has 392.15M shares outstanding. The number of shares has increased by -2.15% in one year.

Shares Outstanding	392.15M
Shares Change (YoY)	-2.15%
Shares Change (QoQ)	0.34%
Owned by Institutions (%)	91.1%
Shares Floating	387.01M
Failed to Deliver (FTD) Shares	464
FTD / Avg. Volume	0.01%

Short Selling Information

The latest short interest is 8.89M, so 2.27% of the outstanding shares have been sold short.

Short Interest	8.89M
Short % of Shares Out	2.27%
Short % of Float	2.91%
Short Ratio (days to cover)	3.07

Valuation Ratios

The PE ratio is 54.61 and the forward PE ratio is 30.46. DexCom's PEG ratio is 39.32.

PE Ratio	54.61
Forward PE	30.46
PS Ratio	7.8
Forward PS	5.7
PB Ratio	14.97
P/FCF Ratio	49.89
PEG Ratio	39.32

Financial Ratio History

Enterprise Valuation

DexCom has an Enterprise Value (EV) of 33.45B.

EV / Sales	8.29
EV / EBITDA	35.37
EV / EBIT	33.8
EV / FCF	53.03

Financial Position

The company has a current ratio of 1.47, with a Debt / Equity ratio of 1.23.

Current Ratio	1.47
Quick Ratio	1.28
Debt / Equity	1.23
Debt / EBITDA	2.74
Debt / FCF	4.1
Interest Coverage	31.58

Financial Efficiency

Return on Equity is 27.4% and Return on Invested Capital is 10.2%.

Return on Equity	27.4%
Return on Assets	8.89%
Return on Invested Capital	10.2%
Revenue Per Employee	$395.39K
Profits Per Employee	$56.49K
Employee Count	10,200
Asset Turnover	0.62
Inventory Turnover	2.94

Taxes

Income Tax	132.8M
Effective Tax Rate	18.73%

Stock Price Statistics

The stock price has increased by 9.27% in the last 52 weeks. The beta is 1.44, so DexCom's price volatility has been higher than the market average.

Beta	1.44
52-Week Price Change	9.27%
50-Day Moving Average	83.83
200-Day Moving Average	79.34
Relative Strength Index (RSI)	40.72
Average Volume (20 Days)	3,456,153

Income Statement

In the last 12 months, DexCom had revenue of 4.03B and earned 576.2M in profits. Earnings per share was 1.46.

Revenue	4.03B
Gross Profit	2.44B
Operating Income	600M
Net Income	576.2M
EBITDA	945.7M
EBIT	728M
Earnings Per Share (EPS)	1.46

Full Income Statement

Balance Sheet

The company has 606.1M in cash and 2.59B in debt, giving a net cash position of -1.98B.

Cash & Cash Equivalents	606.1M
Total Debt	2.59B
Net Cash	-1.98B
Retained Earnings	1.6B
Total Assets	7.33B
Working Capital	1.72B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 989.5M and capital expenditures -358.8M, giving a free cash flow of 630.7M.

Operating Cash Flow	989.5M
Capital Expenditures	-358.8M
Free Cash Flow	630.7M
FCF Per Share	1.56

Full Cash Flow Statement

Margins

Gross margin is 60.46%, with operating and profit margins of 14.88% and 14.29%.

Gross Margin	60.46%
Operating Margin	14.88%
Pretax Margin	17.58%
Profit Margin	14.29%
EBITDA Margin	23.45%
EBIT Margin	14.88%
FCF Margin	15.64%

Dividends & Yields

DXCM does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Payout Ratio	n/a
Earnings Yield	1.83%
FCF Yield	2%

Dividend Details

Analyst Forecast

The average price target for DXCM is $102, which is 31% higher than the current price. The consensus rating is "Buy".

Price Target	$102
Price Target Difference	31%
Analyst Consensus	Buy
Analyst Count	19

Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	$7.3
Lynch Upside	-90.63%
Graham Number	12.9
Graham Upside	-83.44%

Stock Splits

The last stock split was on Jun 13, 2022. It was a forward split with a ratio of 4:1.

Last Split Date	Jun 13, 2022
Split Type	forward
Split Ratio	4:1

Scores

Altman Z-Score	5.49
Piotroski F-Score	7

DexCom Inc. (DXCM)